Zhang F et al. [11] revealed that lncRNA FENDRR restricted the expression of MDR1 via interacting HuR and miR-184 in CML cells, thereby reducing adriamycin resistance. The gene discussed is ELAVL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.